Worldwide Next-Generation Sequencing Industry to 2025 - Key Drivers and Trends prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ The "Cell-based Assays Market" report has been added to SpendEdge s library which is trusted by more than 100 CPOs and 500 category managers.
The market witnessed a slight decline in the sales of
ALK inhibitors in 2020 as several scheduled treatments were either delayed or postponed. Besides, the high incidence of COVID-19 in the second wave has limited the movement of people, which has disrupted the supply chain and logistic operations. These factors are expected to hinder the growth of the ALK inhibitors market to some extent during the forecast period.
The market is expected to be driven by factors such as the high target affinity and specificity of ALK inhibitors, the high prevalence of lung cancer, and the presence of patient assistance programs.
Operator
Good morning, and welcome to the Bio-Techne Earnings Conference Call for the Third Quarter of Fiscal Year 2021. At this time, all participants have been placed in listen-only mode and the call will be open for questions following management s prepared remarks. During our Q&A session, please limit yourself to one question and a follow-up.
I would now like to turn the call over to David Clair, Bio-Techne s Senior Director, Investor Relations and Corporate Development.
David Clair
Senior Director-Investor Relations and Corporate Development
Good morning, and thank you for joining us. On the call with me this morning are Chuck Kummeth, Chief Executive Officer; and Jim Hippel, Chief Financial Officer of Bio-Techne.
Share this article
NEW YORK, April 27, 2021 /PRNewswire/
The in situ hybridization (ISH) market is set to grow by USD 475.05 million, progressing at a CAGR of about 7% during 2021-2025. The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment.
Technavio has announced its latest market research report titled In Situ Hybridization Market by Technology, End-user, and Geography - Forecast and Analysis 2021-2025
The market is fragmented, and the degree of fragmentation will accelerate during the forecast period. Abbott Laboratories, Agilent Technologies Inc., Bio-Rad Laboratories Inc., Bio-Techne Corp., F. Hoffmann-La Roche Ltd., Merck KGaA, NeoGenomics Laboratories, Inc., PerkinElmer Inc., QIAGEN NV, and Thermo Fisher Scientific Inc. are some of the major market participants. The increasing demand for companion diagnostic tests will offer immense growth opportunities. To leverage the current